Market Outlook
The global Biobanking market size was valued at USD 3020 million in 2022 and is forecast to a readjusted size of USD 4724.9 million by 2029 with a CAGR of 6.6% during review period.
Biobank is a biorepository for the preservation and collection of biological material used for diagnosis, biodiversity studies, and research. Depending on the aims of research, different biobanks store different kinds of samples such as tissues, blood, serum, DNA, and RNA.
Global Biobanking key players include Thermo Fisher, Beckman Coulter, Panasonic, etc. Global top three manufacturers hold a share over 15%. United States is the largest market, with a share over 40%, followed by China, and Europe, both have a share about 50 percent. In terms of product, Consumable is the largest segment, with a share about 55%. And in terms of application, the largest application is Population Biobanks, followed by Tissue Biobanks, Virtual Biobanks, etc.
This report is a detailed and comprehensive analysis for global Biobanking market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Biobanking market size and forecasts, in consumption value ($ Million), 2018-2029
Global Biobanking market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Biobanking market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Biobanking market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Biobanking
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Biobanking market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Key Market Players
Thermo Fisher
Beckman Coulter
Panasonic
SOL Group
Promega
Merck
Greiner Bio One
Chart Industries
Brooks Life Science
Tecan Group
QIAGEN
BD
Lifeline Scientific
Hamilton
So-Low
TTP Labtech Ltd
Biolife Solutions
DNA Genotek
Custom Biogenic Systems
LVL Technologies
BioRep
Segmentation By Type
Equipment
Consumable
Segmentation By Application
Virtual Biobanks
Tissue Biobanks
Population Biobanks
Segmentation By Region
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Market SWOT Analysis
What are the strengths of the Biobanking Market in 2025?
The biobanking market in 2025 is expected to benefit from advanced technologies like AI and machine learning, which enhance data analysis and storage efficiency. Additionally, increased government funding and the rise of personalized medicine drive demand for high-quality biological samples. The growing emphasis on genomics and precision medicine also boosts the market, as biobanks provide essential resources for research and development.
What weaknesses may impact the Biobanking Market in 2025?
A major weakness could be the challenges related to standardization and quality control across biobanks, which may lead to discrepancies in sample consistency and research outcomes. Legal and ethical issues surrounding consent, privacy, and ownership of biological materials may also cause delays or restrictions in market growth. Furthermore, the high operational and maintenance costs of biobanks can be a barrier for some institutions.
What opportunities exist for the Biobanking Market in 2025?
There are ample opportunities for the biobanking market to expand with the growing demand for genomic data in drug development and disease prevention. Collaborations with pharmaceutical companies and healthcare organizations offer significant growth potential. Moreover, advancements in cryopreservation technologies could improve sample preservation, leading to broader use across various research fields, such as regenerative medicine.
What threats could hinder the Biobanking Market in 2025?
Threats to the market include the potential for regulatory changes or increased government oversight, which could create additional compliance burdens. Technological challenges, such as cybersecurity risks to sensitive genetic data, could undermine public trust in biobanks. Additionally, competition from alternative data storage methods or non-traditional biorepositories could pose a challenge to market dominance.
Market PESTEL Analysis
What political factors will influence the Biobanking Market in 2025?
Government policies on healthcare funding, public health, and ethical regulations will play a significant role in the biobanking market. Political stability and international collaboration on research initiatives could foster growth, while regulatory frameworks on data privacy and consent may impose challenges. Furthermore, shifting political priorities around healthcare innovation and biotechnology could either accelerate or slow down investment in biobanks.
How will economic factors affect the Biobanking Market in 2025?
Economic factors such as the availability of funding for research and development will greatly influence the market. Economic downturns or recessions could reduce public and private investment in biobanking infrastructure, whereas an economic upturn may increase funding. Additionally, the growing demand for precision medicine and tailored treatments could drive market growth, but high operational costs may limit access for smaller research institutions.
What social factors will impact the Biobanking Market in 2025?
Society's increasing interest in personalized medicine, genomics, and public health initiatives will create more demand for biobanks. However, public trust and acceptance of biobanking practices, especially regarding consent and privacy concerns, will be crucial. Cultural factors around privacy, ownership of genetic data, and willingness to donate biological samples could significantly affect market growth.
What technological advancements will shape the Biobanking Market in 2025?
Technological progress in data storage, sample preservation, and genomic sequencing will be key drivers in the biobanking market. Innovations in AI and machine learning will improve data analysis, while better cryopreservation technologies will enhance the quality and longevity of biological samples. These advances could lower operational costs and increase efficiency, ultimately driving broader use of biobanks across multiple sectors.
What environmental factors need to be considered in the Biobanking Market in 2025?
Sustainability in biobanking practices will be an increasing concern. Environmental factors such as energy consumption for storage facilities and waste management from biological samples will come under scrutiny. There may also be pressure to adopt eco-friendly technologies in biobank operations, which could affect long-term operational costs and regulations.
How will legal factors influence the Biobanking Market in 2025?
Legal factors surrounding the collection, storage, and usage of biological samples will continue to evolve. Stringent laws regarding data privacy, intellectual property rights, and informed consent will impact biobank operations. Legal challenges concerning the ownership of genetic data and access to biobank resources could create complex barriers to market expansion.
Market SIPOC Analysis
Who are the suppliers in the Biobanking Market in 2025?
Suppliers in the biobanking market include biotechnology companies that provide advanced storage and preservation technologies, laboratory equipment manufacturers, data management software developers, and genomic sequencing providers. Additionally, suppliers also consist of research institutions and healthcare organizations offering biological samples and related services.
What inputs are required for the Biobanking Market in 2025?
Inputs required include high-quality biological samples (e.g., blood, tissues, DNA), specialized equipment for sample preservation (e.g., cryogenic storage systems), advanced software for data management, and skilled personnel for handling and processing samples. Additionally, legal and ethical frameworks for obtaining informed consent are critical inputs.
What processes are involved in the Biobanking Market in 2025?
Key processes include the collection, processing, and storage of biological samples, alongside the management of sample data through secure databases. Quality control measures ensure sample integrity, while compliance with legal and ethical standards is crucial. Data analysis and sample distribution to researchers and pharmaceutical companies are also essential processes.
Who are the customers of the Biobanking Market in 2025?
Customers of the biobanking market include pharmaceutical and biotechnology companies, academic and research institutions, healthcare providers, and clinical researchers. Additionally, government agencies and non-profit organizations focused on public health and disease prevention are key customers seeking biological samples for research and development.
What outputs are produced in the Biobanking Market in 2025?
The primary outputs include high-quality biological samples and associated data, which are stored and made available for research and clinical studies. Additionally, biobanks provide research findings, data analysis, and insights for pharmaceutical companies and medical researchers, aiding in drug discovery, disease prevention, and personalized medicine.
Market Porter's Five Forces
What is the threat of new entrants in the Biobanking Market in 2025?
The threat of new entrants is moderate. While the biobanking market offers significant growth opportunities, the high capital investment required for establishing biobank infrastructure, coupled with regulatory hurdles and the need for specialized knowledge, creates a barrier for new players. However, technological advancements and partnerships with research institutions may lower some entry barriers.
How strong is the bargaining power of suppliers in the Biobanking Market in 2025?
The bargaining power of suppliers is moderate to high. Suppliers of critical technologies such as genomic sequencing tools, cryopreservation systems, and data management software have significant leverage, as biobanks rely on high-quality equipment and services to function. However, the growing number of technology providers and increasing competition can somewhat reduce supplier power.
How intense is the competitive rivalry in the Biobanking Market in 2025?
Competitive rivalry is expected to be high in 2025. Established players, such as large biobanks and research institutions, will face competition from emerging biotechnology firms and international collaborations aiming to expand their sample repositories. Innovation in sample preservation and data management technologies, along with the increasing demand for genomic data, will drive this competition.
What is the threat of substitute products or services in the Biobanking Market in 2025?
The threat of substitutes is moderate. While biobanks are crucial for storing biological samples and data, alternatives like virtual biobanks, digital health platforms, and crowdsourced genetic data repositories are emerging. These substitutes may offer more accessible, cost-effective solutions, although they may not provide the same level of data integrity and long-term preservation as traditional biobanks.
How strong is the bargaining power of buyers in the Biobanking Market in 2025?
The bargaining power of buyers is moderate. Pharmaceutical companies, research institutions, and healthcare providers are important customers of biobanks, and their demand for high-quality samples and data is increasing. However, as the market becomes more specialized, buyers have fewer alternatives, and biobanks with advanced technologies and larger sample collections may have more leverage in negotiations.
Market Upstream Analysis
What are the key upstream factors influencing the Biobanking Market in 2025?
Upstream factors include advancements in biotechnology, such as improvements in genomic sequencing, cryopreservation, and data management technologies. Additionally, the availability of high-quality biological samples from healthcare providers, academic institutions, and donors is critical for biobank operations. Collaborations with pharmaceutical companies for drug discovery and clinical trials also influence the supply chain.
How does the availability of technology impact the Biobanking Market in 2025?
Technological advancements play a vital role in the biobanking market. Developments in AI, machine learning, and data analytics enhance the management and processing of vast amounts of genetic data. Improved sample preservation technologies, such as advanced cryopreservation techniques, ensure sample integrity for longer periods, making them more valuable for research and clinical applications.
What are the challenges faced by upstream suppliers in the Biobanking Market in 2025?
Suppliers face challenges related to maintaining the high quality and consistency of biological samples across different biobanks. Additionally, regulatory requirements for data privacy, ethical consent, and sample tracking can be complex and vary by region, which makes compliance challenging. Technological costs, particularly for cutting-edge equipment and software, can also be a barrier for smaller suppliers.
How does regulation affect upstream operations in the Biobanking Market in 2025?
Regulations around data privacy, informed consent, and ethical sample collection are crucial upstream considerations. Stricter laws, such as those governing genetic data, require suppliers to ensure compliance with various national and international standards. Failure to meet these regulations could lead to legal complications, affecting both the supply of samples and the overall operations of biobanks.
What role do partnerships play in the upstream supply chain of the Biobanking Market in 2025?
Partnerships between biobanks, technology providers, and research institutions are increasingly important. Collaborations help facilitate access to cutting-edge technologies, enhance data analytics capabilities, and provide access to diverse biological sample repositories. These partnerships can also drive innovation in sample collection and preservation methods, improving the overall efficiency and output of biobank operations.
Market Midstream Analysis
What are the key midstream activities in the Biobanking Market in 2025?
Midstream activities focus on the collection, processing, and storage of biological samples. This includes tasks like sample preparation, labeling, cataloging, and ensuring proper storage conditions, such as cryopreservation. Data management and ensuring the integrity of both biological samples and associated data are also critical midstream processes, as they support accurate research and clinical trials.
How does data management impact the midstream of the Biobanking Market in 2025?
Data management is central to midstream operations. As biobanks handle vast amounts of genetic data, accurate and secure data storage systems are essential for organizing, tracking, and retrieving samples. Advanced data management systems, including cloud storage and secure databases, help ensure compliance with privacy regulations while enabling researchers to access accurate data efficiently.
What are the logistical challenges in midstream biobanking operations in 2025?
Logistical challenges include maintaining the temperature and integrity of biological samples during transportation and storage. Effective tracking and monitoring systems are necessary to prevent sample degradation. Additionally, the complexity of managing a large number of samples and ensuring proper documentation for each one requires robust systems and efficient workflows to avoid errors and contamination.
How do quality control and assurance processes affect the midstream of the Biobanking Market?
Quality control and assurance processes are essential to ensuring that biological samples maintain their integrity and consistency. This includes regular checks for sample contamination, verification of storage conditions, and validation of data accuracy. Strict quality standards ensure that the samples are reliable for research and clinical trials, making them highly valuable to end-users such as pharmaceutical companies and academic institutions.
How do midstream players collaborate with downstream stakeholders in the Biobanking Market in 2025?
Midstream players, including biobank operators and data managers, collaborate closely with downstream stakeholders like pharmaceutical companies, researchers, and healthcare providers. These collaborations often involve the sharing of high-quality, well-preserved biological samples for clinical trials, drug development, and disease research. Smooth communication and data-sharing protocols are essential to ensure that the samples meet the specific needs of downstream users, facilitating efficient and successful research outcomes.
Market Downstream Analysis
What are the key downstream activities in the Biobanking Market in 2025?
Downstream activities in the biobanking market focus on the utilization of stored biological samples for research, clinical trials, and product development. These activities include data analysis, genetic sequencing, biomarker discovery, and drug development. Biobank samples are also used to study disease progression, conduct epidemiological research, and create personalized medicine solutions.
How does the demand for personalized medicine affect downstream operations in the Biobanking Market?
The growing demand for personalized medicine drives the need for highly specific biological samples and data. As personalized treatments become more prevalent, pharmaceutical companies and researchers increasingly rely on biobanks for tailored data on genetic variations and disease biomarkers. This trend accelerates the use of biobank samples in drug development and clinical applications, influencing the market's growth.
What are the challenges faced by downstream stakeholders in the Biobanking Market in 2025?
Downstream stakeholders face challenges related to data privacy, the complexity of analyzing large datasets, and ensuring the quality and consistency of biological samples. Additionally, the integration of biobank samples into research and clinical trials often requires compliance with strict regulatory standards, which can slow down timelines and increase costs. Ensuring that samples meet specific needs for targeted research is another challenge.
How do regulatory requirements impact downstream players in the Biobanking Market?
Regulatory requirements, particularly around data privacy, consent, and sample usage, play a significant role in downstream activities. Compliance with ethical standards and national/international laws ensures that samples are used appropriately and with full consent from donors. These regulations can add complexity and costs to the process but are essential for maintaining public trust and ensuring ethical research practices.
How do downstream stakeholders collaborate with upstream and midstream players in the Biobanking Market in 2025?
Downstream stakeholders, including pharmaceutical companies, academic researchers, and healthcare providers, collaborate closely with upstream (sample providers) and midstream (biobank operators) players. Effective collaboration ensures that the samples are of high quality and meet the specific research or clinical requirements. Communication between these groups is critical for ensuring the smooth flow of samples, data, and results, enabling efficient use of biobank resources.
Chapter 1, to describe Biobanking product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Biobanking, with revenue, gross margin and global market share of Biobanking from 2018 to 2023.
Chapter 3, the Biobanking competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Biobanking market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Biobanking.
Chapter 13, to describe Biobanking research findings and conclusion.
1 Market Overview
1.1 Product Overview and Scope of Biobanking
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Biobanking by Type
1.3.1 Overview: Global Biobanking Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Biobanking Consumption Value Market Share by Type in 2022
1.3.3 Equipment
1.3.4 Consumable
1.4 Global Biobanking Market by Application
1.4.1 Overview: Global Biobanking Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Virtual Biobanks
1.4.3 Tissue Biobanks
1.4.4 Population Biobanks
1.5 Global Biobanking Market Size & Forecast
1.6 Global Biobanking Market Size and Forecast by Region
1.6.1 Global Biobanking Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Biobanking Market Size by Region, (2018-2029)
1.6.3 North America Biobanking Market Size and Prospect (2018-2029)
1.6.4 Europe Biobanking Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Biobanking Market Size and Prospect (2018-2029)
1.6.6 South America Biobanking Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Biobanking Market Size and Prospect (2018-2029)
2 Company Profiles
2.1 Thermo Fisher
2.1.1 Thermo Fisher Details
2.1.2 Thermo Fisher Major Business
2.1.3 Thermo Fisher Biobanking Product and Solutions
2.1.4 Thermo Fisher Biobanking Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Thermo Fisher Recent Developments and Future Plans
2.2 Beckman Coulter
2.2.1 Beckman Coulter Details
2.2.2 Beckman Coulter Major Business
2.2.3 Beckman Coulter Biobanking Product and Solutions
2.2.4 Beckman Coulter Biobanking Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Beckman Coulter Recent Developments and Future Plans
2.3 Panasonic
2.3.1 Panasonic Details
2.3.2 Panasonic Major Business
2.3.3 Panasonic Biobanking Product and Solutions
2.3.4 Panasonic Biobanking Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Panasonic Recent Developments and Future Plans
2.4 SOL Group
2.4.1 SOL Group Details
2.4.2 SOL Group Major Business
2.4.3 SOL Group Biobanking Product and Solutions
2.4.4 SOL Group Biobanking Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 SOL Group Recent Developments and Future Plans
2.5 Promega
2.5.1 Promega Details
2.5.2 Promega Major Business
2.5.3 Promega Biobanking Product and Solutions
2.5.4 Promega Biobanking Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Promega Recent Developments and Future Plans
2.6 Merck
2.6.1 Merck Details
2.6.2 Merck Major Business
2.6.3 Merck Biobanking Product and Solutions
2.6.4 Merck Biobanking Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Merck Recent Developments and Future Plans
2.7 Greiner Bio One
2.7.1 Greiner Bio One Details
2.7.2 Greiner Bio One Major Business
2.7.3 Greiner Bio One Biobanking Product and Solutions
2.7.4 Greiner Bio One Biobanking Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Greiner Bio One Recent Developments and Future Plans
2.8 Chart Industries
2.8.1 Chart Industries Details
2.8.2 Chart Industries Major Business
2.8.3 Chart Industries Biobanking Product and Solutions
2.8.4 Chart Industries Biobanking Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Chart Industries Recent Developments and Future Plans
2.9 Brooks Life Science
2.9.1 Brooks Life Science Details
2.9.2 Brooks Life Science Major Business
2.9.3 Brooks Life Science Biobanking Product and Solutions
2.9.4 Brooks Life Science Biobanking Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Brooks Life Science Recent Developments and Future Plans
2.10 Tecan Group
2.10.1 Tecan Group Details
2.10.2 Tecan Group Major Business
2.10.3 Tecan Group Biobanking Product and Solutions
2.10.4 Tecan Group Biobanking Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Tecan Group Recent Developments and Future Plans
2.11 QIAGEN
2.11.1 QIAGEN Details
2.11.2 QIAGEN Major Business
2.11.3 QIAGEN Biobanking Product and Solutions
2.11.4 QIAGEN Biobanking Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 QIAGEN Recent Developments and Future Plans
2.12 BD
2.12.1 BD Details
2.12.2 BD Major Business
2.12.3 BD Biobanking Product and Solutions
2.12.4 BD Biobanking Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 BD Recent Developments and Future Plans
2.13 Lifeline Scientific
2.13.1 Lifeline Scientific Details
2.13.2 Lifeline Scientific Major Business
2.13.3 Lifeline Scientific Biobanking Product and Solutions
2.13.4 Lifeline Scientific Biobanking Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Lifeline Scientific Recent Developments and Future Plans
2.14 Hamilton
2.14.1 Hamilton Details
2.14.2 Hamilton Major Business
2.14.3 Hamilton Biobanking Product and Solutions
2.14.4 Hamilton Biobanking Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Hamilton Recent Developments and Future Plans
2.15 So-Low
2.15.1 So-Low Details
2.15.2 So-Low Major Business
2.15.3 So-Low Biobanking Product and Solutions
2.15.4 So-Low Biobanking Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 So-Low Recent Developments and Future Plans
2.16 TTP Labtech Ltd
2.16.1 TTP Labtech Ltd Details
2.16.2 TTP Labtech Ltd Major Business
2.16.3 TTP Labtech Ltd Biobanking Product and Solutions
2.16.4 TTP Labtech Ltd Biobanking Revenue, Gross Margin and Market Share (2018-2023)
2.16.5 TTP Labtech Ltd Recent Developments and Future Plans
2.17 Biolife Solutions
2.17.1 Biolife Solutions Details
2.17.2 Biolife Solutions Major Business
2.17.3 Biolife Solutions Biobanking Product and Solutions
2.17.4 Biolife Solutions Biobanking Revenue, Gross Margin and Market Share (2018-2023)
2.17.5 Biolife Solutions Recent Developments and Future Plans
2.18 DNA Genotek
2.18.1 DNA Genotek Details
2.18.2 DNA Genotek Major Business
2.18.3 DNA Genotek Biobanking Product and Solutions
2.18.4 DNA Genotek Biobanking Revenue, Gross Margin and Market Share (2018-2023)
2.18.5 DNA Genotek Recent Developments and Future Plans
2.19 Custom Biogenic Systems
2.19.1 Custom Biogenic Systems Details
2.19.2 Custom Biogenic Systems Major Business
2.19.3 Custom Biogenic Systems Biobanking Product and Solutions
2.19.4 Custom Biogenic Systems Biobanking Revenue, Gross Margin and Market Share (2018-2023)
2.19.5 Custom Biogenic Systems Recent Developments and Future Plans
2.20 LVL Technologies
2.20.1 LVL Technologies Details
2.20.2 LVL Technologies Major Business
2.20.3 LVL Technologies Biobanking Product and Solutions
2.20.4 LVL Technologies Biobanking Revenue, Gross Margin and Market Share (2018-2023)
2.20.5 LVL Technologies Recent Developments and Future Plans
2.21 BioRep
2.21.1 BioRep Details
2.21.2 BioRep Major Business
2.21.3 BioRep Biobanking Product and Solutions
2.21.4 BioRep Biobanking Revenue, Gross Margin and Market Share (2018-2023)
2.21.5 BioRep Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Biobanking Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Biobanking by Company Revenue
3.2.2 Top 3 Biobanking Players Market Share in 2022
3.2.3 Top 6 Biobanking Players Market Share in 2022
3.3 Biobanking Market: Overall Company Footprint Analysis
3.3.1 Biobanking Market: Region Footprint
3.3.2 Biobanking Market: Company Product Type Footprint
3.3.3 Biobanking Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
4.1 Global Biobanking Consumption Value and Market Share by Type (2018-2023)
4.2 Global Biobanking Market Forecast by Type (2024-2029)
5 Market Size Segment by Application
5.1 Global Biobanking Consumption Value Market Share by Application (2018-2023)
5.2 Global Biobanking Market Forecast by Application (2024-2029)
6 North America
6.1 North America Biobanking Consumption Value by Type (2018-2029)
6.2 North America Biobanking Consumption Value by Application (2018-2029)
6.3 North America Biobanking Market Size by Country
6.3.1 North America Biobanking Consumption Value by Country (2018-2029)
6.3.2 United States Biobanking Market Size and Forecast (2018-2029)
6.3.3 Canada Biobanking Market Size and Forecast (2018-2029)
6.3.4 Mexico Biobanking Market Size and Forecast (2018-2029)
7 Europe
7.1 Europe Biobanking Consumption Value by Type (2018-2029)
7.2 Europe Biobanking Consumption Value by Application (2018-2029)
7.3 Europe Biobanking Market Size by Country
7.3.1 Europe Biobanking Consumption Value by Country (2018-2029)
7.3.2 Germany Biobanking Market Size and Forecast (2018-2029)
7.3.3 France Biobanking Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Biobanking Market Size and Forecast (2018-2029)
7.3.5 Russia Biobanking Market Size and Forecast (2018-2029)
7.3.6 Italy Biobanking Market Size and Forecast (2018-2029)
8 Asia-Pacific
8.1 Asia-Pacific Biobanking Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Biobanking Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Biobanking Market Size by Region
8.3.1 Asia-Pacific Biobanking Consumption Value by Region (2018-2029)
8.3.2 China Biobanking Market Size and Forecast (2018-2029)
8.3.3 Japan Biobanking Market Size and Forecast (2018-2029)
8.3.4 South Korea Biobanking Market Size and Forecast (2018-2029)
8.3.5 India Biobanking Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Biobanking Market Size and Forecast (2018-2029)
8.3.7 Australia Biobanking Market Size and Forecast (2018-2029)
9 South America
9.1 South America Biobanking Consumption Value by Type (2018-2029)
9.2 South America Biobanking Consumption Value by Application (2018-2029)
9.3 South America Biobanking Market Size by Country
9.3.1 South America Biobanking Consumption Value by Country (2018-2029)
9.3.2 Brazil Biobanking Market Size and Forecast (2018-2029)
9.3.3 Argentina Biobanking Market Size and Forecast (2018-2029)
10 Middle East & Africa
10.1 Middle East & Africa Biobanking Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Biobanking Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Biobanking Market Size by Country
10.3.1 Middle East & Africa Biobanking Consumption Value by Country (2018-2029)
10.3.2 Turkey Biobanking Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Biobanking Market Size and Forecast (2018-2029)
10.3.4 UAE Biobanking Market Size and Forecast (2018-2029)
11 Market Dynamics
11.1 Biobanking Market Drivers
11.2 Biobanking Market Restraints
11.3 Biobanking Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 Industry Chain Analysis
12.1 Biobanking Industry Chain
12.2 Biobanking Upstream Analysis
12.3 Biobanking Midstream Analysis
12.4 Biobanking Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
List of Tables
Table 1. Global Biobanking Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Biobanking Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global Biobanking Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Biobanking Consumption Value by Region (2024-2029) & (USD Million)
Table 5. Thermo Fisher Company Information, Head Office, and Major Competitors
Table 6. Thermo Fisher Major Business
Table 7. Thermo Fisher Biobanking Product and Solutions
Table 8. Thermo Fisher Biobanking Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. Thermo Fisher Recent Developments and Future Plans
Table 10. Beckman Coulter Company Information, Head Office, and Major Competitors
Table 11. Beckman Coulter Major Business
Table 12. Beckman Coulter Biobanking Product and Solutions
Table 13. Beckman Coulter Biobanking Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. Beckman Coulter Recent Developments and Future Plans
Table 15. Panasonic Company Information, Head Office, and Major Competitors
Table 16. Panasonic Major Business
Table 17. Panasonic Biobanking Product and Solutions
Table 18. Panasonic Biobanking Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. Panasonic Recent Developments and Future Plans
Table 20. SOL Group Company Information, Head Office, and Major Competitors
Table 21. SOL Group Major Business
Table 22. SOL Group Biobanking Product and Solutions
Table 23. SOL Group Biobanking Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. SOL Group Recent Developments and Future Plans
Table 25. Promega Company Information, Head Office, and Major Competitors
Table 26. Promega Major Business
Table 27. Promega Biobanking Product and Solutions
Table 28. Promega Biobanking Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. Promega Recent Developments and Future Plans
Table 30. Merck Company Information, Head Office, and Major Competitors
Table 31. Merck Major Business
Table 32. Merck Biobanking Product and Solutions
Table 33. Merck Biobanking Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. Merck Recent Developments and Future Plans
Table 35. Greiner Bio One Company Information, Head Office, and Major Competitors
Table 36. Greiner Bio One Major Business
Table 37. Greiner Bio One Biobanking Product and Solutions
Table 38. Greiner Bio One Biobanking Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. Greiner Bio One Recent Developments and Future Plans
Table 40. Chart Industries Company Information, Head Office, and Major Competitors
Table 41. Chart Industries Major Business
Table 42. Chart Industries Biobanking Product and Solutions
Table 43. Chart Industries Biobanking Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. Chart Industries Recent Developments and Future Plans
Table 45. Brooks Life Science Company Information, Head Office, and Major Competitors
Table 46. Brooks Life Science Major Business
Table 47. Brooks Life Science Biobanking Product and Solutions
Table 48. Brooks Life Science Biobanking Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 49. Brooks Life Science Recent Developments and Future Plans
Table 50. Tecan Group Company Information, Head Office, and Major Competitors
Table 51. Tecan Group Major Business
Table 52. Tecan Group Biobanking Product and Solutions
Table 53. Tecan Group Biobanking Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 54. Tecan Group Recent Developments and Future Plans
Table 55. QIAGEN Company Information, Head Office, and Major Competitors
Table 56. QIAGEN Major Business
Table 57. QIAGEN Biobanking Product and Solutions
Table 58. QIAGEN Biobanking Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 59. QIAGEN Recent Developments and Future Plans
Table 60. BD Company Information, Head Office, and Major Competitors
Table 61. BD Major Business
Table 62. BD Biobanking Product and Solutions
Table 63. BD Biobanking Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 64. BD Recent Developments and Future Plans
Table 65. Lifeline Scientific Company Information, Head Office, and Major Competitors
Table 66. Lifeline Scientific Major Business
Table 67. Lifeline Scientific Biobanking Product and Solutions
Table 68. Lifeline Scientific Biobanking Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 69. Lifeline Scientific Recent Developments and Future Plans
Table 70. Hamilton Company Information, Head Office, and Major Competitors
Table 71. Hamilton Major Business
Table 72. Hamilton Biobanking Product and Solutions
Table 73. Hamilton Biobanking Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 74. Hamilton Recent Developments and Future Plans
Table 75. So-Low Company Information, Head Office, and Major Competitors
Table 76. So-Low Major Business
Table 77. So-Low Biobanking Product and Solutions
Table 78. So-Low Biobanking Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 79. So-Low Recent Developments and Future Plans
Table 80. TTP Labtech Ltd Company Information, Head Office, and Major Competitors
Table 81. TTP Labtech Ltd Major Business
Table 82. TTP Labtech Ltd Biobanking Product and Solutions
Table 83. TTP Labtech Ltd Biobanking Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 84. TTP Labtech Ltd Recent Developments and Future Plans
Table 85. Biolife Solutions Company Information, Head Office, and Major Competitors
Table 86. Biolife Solutions Major Business
Table 87. Biolife Solutions Biobanking Product and Solutions
Table 88. Biolife Solutions Biobanking Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Biolife Solutions Recent Developments and Future Plans
Table 90. DNA Genotek Company Information, Head Office, and Major Competitors
Table 91. DNA Genotek Major Business
Table 92. DNA Genotek Biobanking Product and Solutions
Table 93. DNA Genotek Biobanking Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 94. DNA Genotek Recent Developments and Future Plans
Table 95. Custom Biogenic Systems Company Information, Head Office, and Major Competitors
Table 96. Custom Biogenic Systems Major Business
Table 97. Custom Biogenic Systems Biobanking Product and Solutions
Table 98. Custom Biogenic Systems Biobanking Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 99. Custom Biogenic Systems Recent Developments and Future Plans
Table 100. LVL Technologies Company Information, Head Office, and Major Competitors
Table 101. LVL Technologies Major Business
Table 102. LVL Technologies Biobanking Product and Solutions
Table 103. LVL Technologies Biobanking Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 104. LVL Technologies Recent Developments and Future Plans
Table 105. BioRep Company Information, Head Office, and Major Competitors
Table 106. BioRep Major Business
Table 107. BioRep Biobanking Product and Solutions
Table 108. BioRep Biobanking Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 109. BioRep Recent Developments and Future Plans
Table 110. Global Biobanking Revenue (USD Million) by Players (2018-2023)
Table 111. Global Biobanking Revenue Share by Players (2018-2023)
Table 112. Breakdown of Biobanking by Company Type (Tier 1, Tier 2, and Tier 3)
Table 113. Market Position of Players in Biobanking, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 114. Head Office of Key Biobanking Players
Table 115. Biobanking Market: Company Product Type Footprint
Table 116. Biobanking Market: Company Product Application Footprint
Table 117. Biobanking New Market Entrants and Barriers to Market Entry
Table 118. Biobanking Mergers, Acquisition, Agreements, and Collaborations
Table 119. Global Biobanking Consumption Value (USD Million) by Type (2018-2023)
Table 120. Global Biobanking Consumption Value Share by Type (2018-2023)
Table 121. Global Biobanking Consumption Value Forecast by Type (2024-2029)
Table 122. Global Biobanking Consumption Value by Application (2018-2023)
Table 123. Global Biobanking Consumption Value Forecast by Application (2024-2029)
Table 124. North America Biobanking Consumption Value by Type (2018-2023) & (USD Million)
Table 125. North America Biobanking Consumption Value by Type (2024-2029) & (USD Million)
Table 126. North America Biobanking Consumption Value by Application (2018-2023) & (USD Million)
Table 127. North America Biobanking Consumption Value by Application (2024-2029) & (USD Million)
Table 128. North America Biobanking Consumption Value by Country (2018-2023) & (USD Million)
Table 129. North America Biobanking Consumption Value by Country (2024-2029) & (USD Million)
Table 130. Europe Biobanking Consumption Value by Type (2018-2023) & (USD Million)
Table 131. Europe Biobanking Consumption Value by Type (2024-2029) & (USD Million)
Table 132. Europe Biobanking Consumption Value by Application (2018-2023) & (USD Million)
Table 133. Europe Biobanking Consumption Value by Application (2024-2029) & (USD Million)
Table 134. Europe Biobanking Consumption Value by Country (2018-2023) & (USD Million)
Table 135. Europe Biobanking Consumption Value by Country (2024-2029) & (USD Million)
Table 136. Asia-Pacific Biobanking Consumption Value by Type (2018-2023) & (USD Million)
Table 137. Asia-Pacific Biobanking Consumption Value by Type (2024-2029) & (USD Million)
Table 138. Asia-Pacific Biobanking Consumption Value by Application (2018-2023) & (USD Million)
Table 139. Asia-Pacific Biobanking Consumption Value by Application (2024-2029) & (USD Million)
Table 140. Asia-Pacific Biobanking Consumption Value by Region (2018-2023) & (USD Million)
Table 141. Asia-Pacific Biobanking Consumption Value by Region (2024-2029) & (USD Million)
Table 142. South America Biobanking Consumption Value by Type (2018-2023) & (USD Million)
Table 143. South America Biobanking Consumption Value by Type (2024-2029) & (USD Million)
Table 144. South America Biobanking Consumption Value by Application (2018-2023) & (USD Million)
Table 145. South America Biobanking Consumption Value by Application (2024-2029) & (USD Million)
Table 146. South America Biobanking Consumption Value by Country (2018-2023) & (USD Million)
Table 147. South America Biobanking Consumption Value by Country (2024-2029) & (USD Million)
Table 148. Middle East & Africa Biobanking Consumption Value by Type (2018-2023) & (USD Million)
Table 149. Middle East & Africa Biobanking Consumption Value by Type (2024-2029) & (USD Million)
Table 150. Middle East & Africa Biobanking Consumption Value by Application (2018-2023) & (USD Million)
Table 151. Middle East & Africa Biobanking Consumption Value by Application (2024-2029) & (USD Million)
Table 152. Middle East & Africa Biobanking Consumption Value by Country (2018-2023) & (USD Million)
Table 153. Middle East & Africa Biobanking Consumption Value by Country (2024-2029) & (USD Million)
Table 154. Biobanking Raw Material
Table 155. Key Suppliers of Biobanking Raw Materials
List of Figures
Figure 1. Biobanking Picture
Figure 2. Global Biobanking Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Biobanking Consumption Value Market Share by Type in 2022
Figure 4. Equipment
Figure 5. Consumable
Figure 6. Global Biobanking Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 7. Biobanking Consumption Value Market Share by Application in 2022
Figure 8. Virtual Biobanks Picture
Figure 9. Tissue Biobanks Picture
Figure 10. Population Biobanks Picture
Figure 11. Global Biobanking Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 12. Global Biobanking Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 13. Global Market Biobanking Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 14. Global Biobanking Consumption Value Market Share by Region (2018-2029)
Figure 15. Global Biobanking Consumption Value Market Share by Region in 2022
Figure 16. North America Biobanking Consumption Value (2018-2029) & (USD Million)
Figure 17. Europe Biobanking Consumption Value (2018-2029) & (USD Million)
Figure 18. Asia-Pacific Biobanking Consumption Value (2018-2029) & (USD Million)
Figure 19. South America Biobanking Consumption Value (2018-2029) & (USD Million)
Figure 20. Middle East and Africa Biobanking Consumption Value (2018-2029) & (USD Million)
Figure 21. Global Biobanking Revenue Share by Players in 2022
Figure 22. Biobanking Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 23. Global Top 3 Players Biobanking Market Share in 2022
Figure 24. Global Top 6 Players Biobanking Market Share in 2022
Figure 25. Global Biobanking Consumption Value Share by Type (2018-2023)
Figure 26. Global Biobanking Market Share Forecast by Type (2024-2029)
Figure 27. Global Biobanking Consumption Value Share by Application (2018-2023)
Figure 28. Global Biobanking Market Share Forecast by Application (2024-2029)
Figure 29. North America Biobanking Consumption Value Market Share by Type (2018-2029)
Figure 30. North America Biobanking Consumption Value Market Share by Application (2018-2029)
Figure 31. North America Biobanking Consumption Value Market Share by Country (2018-2029)
Figure 32. United States Biobanking Consumption Value (2018-2029) & (USD Million)
Figure 33. Canada Biobanking Consumption Value (2018-2029) & (USD Million)
Figure 34. Mexico Biobanking Consumption Value (2018-2029) & (USD Million)
Figure 35. Europe Biobanking Consumption Value Market Share by Type (2018-2029)
Figure 36. Europe Biobanking Consumption Value Market Share by Application (2018-2029)
Figure 37. Europe Biobanking Consumption Value Market Share by Country (2018-2029)
Figure 38. Germany Biobanking Consumption Value (2018-2029) & (USD Million)
Figure 39. France Biobanking Consumption Value (2018-2029) & (USD Million)
Figure 40. United Kingdom Biobanking Consumption Value (2018-2029) & (USD Million)
Figure 41. Russia Biobanking Consumption Value (2018-2029) & (USD Million)
Figure 42. Italy Biobanking Consumption Value (2018-2029) & (USD Million)
Figure 43. Asia-Pacific Biobanking Consumption Value Market Share by Type (2018-2029)
Figure 44. Asia-Pacific Biobanking Consumption Value Market Share by Application (2018-2029)
Figure 45. Asia-Pacific Biobanking Consumption Value Market Share by Region (2018-2029)
Figure 46. China Biobanking Consumption Value (2018-2029) & (USD Million)
Figure 47. Japan Biobanking Consumption Value (2018-2029) & (USD Million)
Figure 48. South Korea Biobanking Consumption Value (2018-2029) & (USD Million)
Figure 49. India Biobanking Consumption Value (2018-2029) & (USD Million)
Figure 50. Southeast Asia Biobanking Consumption Value (2018-2029) & (USD Million)
Figure 51. Australia Biobanking Consumption Value (2018-2029) & (USD Million)
Figure 52. South America Biobanking Consumption Value Market Share by Type (2018-2029)
Figure 53. South America Biobanking Consumption Value Market Share by Application (2018-2029)
Figure 54. South America Biobanking Consumption Value Market Share by Country (2018-2029)
Figure 55. Brazil Biobanking Consumption Value (2018-2029) & (USD Million)
Figure 56. Argentina Biobanking Consumption Value (2018-2029) & (USD Million)
Figure 57. Middle East and Africa Biobanking Consumption Value Market Share by Type (2018-2029)
Figure 58. Middle East and Africa Biobanking Consumption Value Market Share by Application (2018-2029)
Figure 59. Middle East and Africa Biobanking Consumption Value Market Share by Country (2018-2029)
Figure 60. Turkey Biobanking Consumption Value (2018-2029) & (USD Million)
Figure 61. Saudi Arabia Biobanking Consumption Value (2018-2029) & (USD Million)
Figure 62. UAE Biobanking Consumption Value (2018-2029) & (USD Million)
Figure 63. Biobanking Market Drivers
Figure 64. Biobanking Market Restraints
Figure 65. Biobanking Market Trends
Figure 66. Porters Five Forces Analysis
Figure 67. Manufacturing Cost Structure Analysis of Biobanking in 2022
Figure 68. Manufacturing Process Analysis of Biobanking
Figure 69. Biobanking Industrial Chain
Figure 70. Methodology
Figure 71. Research Process and Data Source
